Generics and Biosimilars Initiative Journal · 2015 · 20 citations · 1 references
PharmacyBiomedical SciencesBiopharmaceuticsPatent LawRegulatory ScienceBiosimilar RegulationMarket Authorization ProceduresNew Drug ApplicationsRegulatory ExclusivityRegulatory PharmacologyBiologic ExclusivityBiosimilar CompetitionBiosimilar MarketingBiotechnology LicensingExclusivity In Drug ApprovalMarket Access For BiosimilarsRecombinant Human Growth HormoneRegulatory Frameworks For Biosimilars
Biosimilars have been approved in Europe since 2006. With patents on originator biologicals expiring and ever-tightening healthcare budgets biosimilars are likely to take an increasing share of the biologicals market. In light of these facts, this article gives estimated patent expiry dates for just some of
1